Bernard Krust
18Patents
5h-index
23Co-inventors
66Inventor score
Filing activity: May 25, 1989 → Aug 27, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5208321A | HIV-2 transmembrane glycoprotein homodimer (GP 80) | Emerging Cross-Sectional Technologies | 9 | Expired |
| US5312902A | Dimer of the precursor of HIV-2 envelope glycoprotein | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5470702A | HIV-2 transmembrane glycoprotein homodimer (gp 80) | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5807992A | HIV-2 transmembrane glycoprotein homodimer (gp 80) | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5407811A | Monoclonal antibodies to GP110 of HIV and hybridomas secreting these antibodies | Emerging Cross-Sectional Technologies | 5 | Expired |
| US6440657B1 | Nucleic acids and peptides of human immunodeficiency virus type (HIV-1) | Chemistry; Metallurgy | 3 | Expired |
| US6261571A | Immunogenic compositions comprising dimeric forms of the human immunodeficiency virus type 2 (HIV-2) and simian immunodeficiency virus (SIV) envelope glycoproteins | Emerging Cross-Sectional Technologies | 3 | Expired |
| US5843638A | Nucleic acids and pepties of human immunodeficiency virus type-1 (HIV-1). | Chemistry; Metallurgy | 3 | Expired |
| US6056963A | Immunogenic compositions comprising glycosylated and deglycosylated monomeric and dimeric forms of HIV-2 enveloped glycoproteins | Chemistry; Metallurgy | 3 | Expired |
| US6608179B1 | Antibodies, that bind to HIV-2 transmembrane glycoprotein homodimer (gp 80) | Emerging Cross-Sectional Technologies | 3 | Expired |
| US5610035A | Methods for the preparation of hybridomas producing lymphadenopathy-associated virus (LAV) GP110-specific monoclonal antibodies and methods for the purification of GP110 employing said monoclonal antibodies | Chemistry; Metallurgy | 2 | Expired |
| US6197496A | Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins gp300, p200, and p90/80 | Chemistry; Metallurgy | 2 | Expired |
| US6984721B2 | Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins GP300, P200, and P90/80 | Chemistry; Metallurgy | 2 | Expired |
| US7507417B2 | Immunogenic compositions comprising human immunodeficiency virus type 2 (HIV-2) glycosylated and unglycosylated envelope proteins and their methods of preparation | Chemistry; Metallurgy | 2 | Active |
| US5550052A | Hybrid cell line formed between T4 lymphocytes and tumoral lymphoid type cells | Chemistry; Metallurgy | 2 | Expired |
| US7364744B2 | Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV | Chemistry; Metallurgy | 1 | Expired |
| US8173767B2 | Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV | Chemistry; Metallurgy | 1 | Active |
| US8790898B2 | Synthetic peptides corresponding to overlapping neutralizing determinants in the CBD1 epitope induce broadly neutralizing antibodies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.